Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TREPROSTINIL Cause Liquid product physical issue? 8 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Liquid product physical issue have been filed in association with TREPROSTINIL (TYVASO). This represents 0.0% of all adverse event reports for TREPROSTINIL.

8
Reports of Liquid product physical issue with TREPROSTINIL
0.0%
of all TREPROSTINIL reports
1
Deaths
4
Hospitalizations

How Dangerous Is Liquid product physical issue From TREPROSTINIL?

Of the 8 reports, 1 (12.5%) resulted in death, 4 (50.0%) required hospitalization, and 1 (12.5%) were considered life-threatening.

Is Liquid product physical issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TREPROSTINIL. However, 8 reports have been filed with the FAERS database.

What Other Side Effects Does TREPROSTINIL Cause?

Dyspnoea (16,348) Headache (14,051) Diarrhoea (11,335) Nausea (10,320) Cough (8,945) Fatigue (7,440) Dizziness (7,405) Infusion site pain (5,169) Vomiting (5,097) Death (4,764)

What Other Drugs Cause Liquid product physical issue?

SOMATROPIN (679) EPINEPHRINE (618) ADALIMUMAB (404) USTEKINUMAB (226) INSULIN ASPART (211) TESTOSTERONE CYPIONATE (195) GUSELKUMAB (194) HUMAN IMMUNOGLOBULIN G (142) ERENUMAB-AOOE (95) BUDESONIDE (92)

Which TREPROSTINIL Alternatives Have Lower Liquid product physical issue Risk?

TREPROSTINIL vs TREPROSTINIL DIOLAMINE TREPROSTINIL vs TRETINOIN TREPROSTINIL vs TRIAMCINOLONE TREPROSTINIL vs TRIAMCINOLONE ACETONIDE TREPROSTINIL vs TRIAMCINOLONE HEXACETONIDE

Related Pages

TREPROSTINIL Full Profile All Liquid product physical issue Reports All Drugs Causing Liquid product physical issue TREPROSTINIL Demographics